Biotechnology and the LawAmerican Bar Association, 2007 - 957 lappuses The book is written to help lawyers faced with the challenge of identifying the legal issues and processes that must be faced by their clients in building, marketing, and protecting a biotech business. The contributors are experts in this specialized area and provide thorough, yet accessible, overviews of biotech subspecialties with an eye to practical application. A biotech legal practice involves specialized subject matter and regulatory schemes that, generally, are not part of the business lawyer's repertoire and which can present many hazards for the uninitiated. Because of the expansion in biotech practice beyond the traditional organizations and their representatives, this guide was written to help lawyers find their way through the biotech maze. |
No grāmatas satura
1.–5. rezultāts no 85.
vii. lappuse
... Interest c . Conflict of Commitment d . Special Knowledge a . Policies and Procedures .... 169 .... 170 171 171 ... Interests of Other Stakeholders 6 . a . Other Underwriters .... b . Government Agencies c . Special Government ...
... Interest c . Conflict of Commitment d . Special Knowledge a . Policies and Procedures .... 169 .... 170 171 171 ... Interests of Other Stakeholders 6 . a . Other Underwriters .... b . Government Agencies c . Special Government ...
x. lappuse
... Interest 4. Friends and Family ......... 5 . a . Securities . b . Corporate Loans ....... 6. Generating Revenues to Reduce or Defer Need for Investment a . Intellectual Property ..... b . Commercial .............. Government Funding 219 ...
... Interest 4. Friends and Family ......... 5 . a . Securities . b . Corporate Loans ....... 6. Generating Revenues to Reduce or Defer Need for Investment a . Intellectual Property ..... b . Commercial .............. Government Funding 219 ...
xiii. lappuse
... , and Employment .... 1 . Grants a . Standards of Conduct ............... b . Financial Conflict of Interest ...... 353 ..... 353 .... 353 .... 353 C. Misconduct in Science and Engineering 2. Contracts ..... ........ Contents xiii.
... , and Employment .... 1 . Grants a . Standards of Conduct ............... b . Financial Conflict of Interest ...... 353 ..... 353 .... 353 .... 353 C. Misconduct in Science and Engineering 2. Contracts ..... ........ Contents xiii.
xiv. lappuse
... Interest ................. ........ 354 b . Employment Discussions With and Hiring of U.S. Government Personnel ............... ....... 356 c . The National Institutes of Health ( NIH ) Government Employee Supplemental Regulations on ...
... Interest ................. ........ 354 b . Employment Discussions With and Hiring of U.S. Government Personnel ............... ....... 356 c . The National Institutes of Health ( NIH ) Government Employee Supplemental Regulations on ...
xli. lappuse
... interest laws counseling , particu- larly on the revolving - door restrictions , U.S. Postal Service discount mail compliance counseling , and advising senior corporate executives on forma- tion of and the parameters of political action ...
... interest laws counseling , particu- larly on the revolving - door restrictions , U.S. Postal Service discount mail compliance counseling , and advising senior corporate executives on forma- tion of and the parameters of political action ...
Saturs
IV | 1 |
VI | 4 |
VIII | 5 |
X | 6 |
XII | 7 |
XIV | 8 |
XVI | 9 |
XVIII | 10 |
CDLXXIV | 484 |
CDLXXVI | 485 |
CDLXXVII | 486 |
CDLXXVIII | 487 |
CDLXXIX | 488 |
CDLXXX | 489 |
CDLXXXI | 490 |
CDLXXXIV | 491 |
XX | 11 |
XXIII | 12 |
XXIV | 13 |
XXV | 25 |
XXIX | 26 |
XXXI | 28 |
XXXII | 29 |
XXXIII | 30 |
XXXIV | 31 |
XXXV | 34 |
XXXVI | 35 |
XXXVII | 38 |
XXXVIII | 39 |
XXXIX | 41 |
XL | 42 |
XLI | 43 |
XLII | 45 |
XLIII | 46 |
XLIV | 49 |
XLV | 51 |
XLVI | 52 |
XLVII | 53 |
XLVIII | 57 |
XLIX | 58 |
LI | 60 |
LII | 62 |
LIII | 63 |
LIV | 64 |
LV | 66 |
LVI | 69 |
LVII | 70 |
LVIII | 72 |
LIX | 73 |
LXII | 74 |
LXIII | 75 |
LXVI | 76 |
LXVIII | 77 |
LXX | 78 |
LXXI | 79 |
LXXIII | 80 |
LXXIV | 81 |
LXXV | 82 |
LXXIX | 83 |
LXXXII | 84 |
LXXXIII | 88 |
LXXXV | 91 |
LXXXVI | 95 |
LXXXVIII | 97 |
LXXXIX | 99 |
XCI | 100 |
XCII | 105 |
XCIII | 107 |
XCIV | 108 |
XCV | 109 |
XCVI | 110 |
XCVII | 111 |
XCIX | 112 |
CI | 113 |
CIII | 114 |
CIV | 115 |
CV | 117 |
CVI | 118 |
CVIII | 119 |
CIX | 121 |
CX | 122 |
CXI | 124 |
CXII | 126 |
CXIII | 127 |
CXIV | 132 |
CXV | 139 |
CXVIII | 140 |
CXX | 141 |
CXXI | 142 |
CXXII | 143 |
CXXIV | 145 |
CXXVI | 146 |
CXXVII | 147 |
CXXVIII | 148 |
CXXIX | 149 |
CXXX | 150 |
CXXXII | 151 |
CXXXIV | 152 |
CXXXVI | 154 |
CXXXVIII | 155 |
CXLI | 156 |
CXLIII | 158 |
CXLV | 160 |
CXLVII | 161 |
CXLVIII | 162 |
CXLIX | 168 |
CL | 169 |
CLI | 170 |
CLII | 171 |
CLIV | 172 |
CLVI | 173 |
CLVII | 174 |
CLVIII | 175 |
CLXI | 176 |
CLXVIII | 177 |
CLXXII | 178 |
CLXXVIII | 179 |
CLXXXIII | 180 |
CLXXXIV | 183 |
CLXXXVI | 184 |
CLXXXVIII | 185 |
CXC | 186 |
CXCII | 187 |
CXCV | 188 |
CXCVII | 189 |
CCII | 190 |
CCIV | 191 |
CCVI | 192 |
CCIX | 193 |
CCXIII | 194 |
CCXVIII | 195 |
CCXXII | 196 |
CCXXIII | 197 |
CCXXVII | 198 |
CCXXVIII | 199 |
CCXXX | 203 |
CCXXXI | 204 |
CCXXXIII | 206 |
CCXXXIV | 209 |
CCXXXV | 210 |
CCXXXVII | 212 |
CCXXXVIII | 213 |
CCXXXIX | 214 |
CCXLI | 215 |
CCXLIII | 216 |
CCXLIV | 217 |
CCXLV | 218 |
CCXLVII | 219 |
CCXLIX | 220 |
CCL | 221 |
CCLII | 222 |
CCLIV | 223 |
CCLVII | 224 |
CCLIX | 225 |
CCLXI | 226 |
CCLXIII | 227 |
CCLXIV | 228 |
CCLXVII | 230 |
CCLXIX | 231 |
CCLXX | 232 |
CCLXXII | 233 |
CCLXXIII | 234 |
CCLXXV | 235 |
CCLXXVII | 236 |
CCLXXVIII | 237 |
CCLXXIX | 239 |
CCLXXXI | 240 |
CCLXXXII | 241 |
CCLXXXIV | 253 |
CCLXXXV | 265 |
CCLXXXVI | 266 |
CCLXXXVII | 267 |
CCLXXXVIII | 268 |
CCLXXXIX | 270 |
CCXC | 271 |
CCXCI | 272 |
CCXCIII | 273 |
CCXCV | 274 |
CCXCVIII | 275 |
CCCII | 276 |
CCCIV | 277 |
CCCVII | 281 |
CCCX | 282 |
CCCXIII | 283 |
CCCXIV | 285 |
CCCXVI | 286 |
CCCXVII | 287 |
CCCXX | 288 |
CCCXXIII | 289 |
CCCXXVII | 290 |
CCCXXIX | 291 |
CCCXXXI | 299 |
CCCXXXIII | 300 |
CCCXXXIV | 301 |
CCCXXXVII | 302 |
CCCXXXIX | 303 |
CCCXLII | 304 |
CCCXLIV | 305 |
CCCXLVI | 307 |
CCCXLVII | 308 |
CCCXLVIII | 309 |
CCCXLIX | 310 |
CCCL | 312 |
CCCLII | 314 |
CCCLIV | 315 |
CCCLV | 318 |
CCCLVI | 325 |
CCCLVII | 326 |
CCCLVIII | 327 |
CCCLIX | 328 |
CCCLX | 330 |
CCCLXII | 331 |
CCCLXIV | 332 |
CCCLXVI | 337 |
CCCLXVII | 340 |
CCCLXVIII | 342 |
CCCLXIX | 344 |
CCCLXXI | 345 |
CCCLXXII | 346 |
CCCLXXIII | 347 |
CCCLXXIV | 348 |
CCCLXXVI | 349 |
CCCLXXVIII | 350 |
CCCLXXIX | 351 |
CCCLXXXI | 352 |
CCCLXXXIV | 353 |
CCCLXXXVII | 354 |
CCCLXXXIX | 356 |
CCCXC | 358 |
CCCXCI | 407 |
CCCXCII | 408 |
CCCXCV | 411 |
CCCXCVI | 412 |
CCCXCVII | 415 |
CCCXCVIII | 417 |
CCCXCIX | 418 |
CD | 419 |
CDI | 420 |
CDII | 421 |
CDIII | 422 |
CDIV | 423 |
CDV | 424 |
CDVIII | 425 |
CDIX | 433 |
CDX | 434 |
CDXII | 438 |
CDXIII | 439 |
CDXIV | 441 |
CDXV | 442 |
CDXVII | 445 |
CDXVIII | 446 |
CDXIX | 449 |
CDXX | 450 |
CDXXI | 451 |
CDXXII | 452 |
CDXXIII | 453 |
CDXXV | 454 |
CDXXVI | 455 |
CDXXVII | 456 |
CDXXXI | 457 |
CDXXXIV | 458 |
CDXXXVII | 459 |
CDXXXIX | 460 |
CDXLII | 461 |
CDXLIV | 462 |
CDXLVI | 463 |
CDXLIX | 464 |
CDLI | 465 |
CDLIII | 469 |
CDLVI | 470 |
CDLVIII | 471 |
CDLIX | 472 |
CDLXI | 475 |
CDLXIV | 476 |
CDLXVII | 477 |
CDLXVIII | 479 |
CDLXIX | 480 |
CDLXX | 481 |
CDLXXIII | 483 |
CDLXXXVI | 493 |
CDLXXXVII | 494 |
CDLXXXVIII | 495 |
CDLXXXIX | 497 |
CDXCI | 498 |
CDXCII | 499 |
CDXCIV | 500 |
CDXCVII | 501 |
CDXCVIII | 509 |
CDXCIX | 512 |
DI | 518 |
DII | 519 |
DIII | 521 |
DV | 523 |
DVI | 524 |
DVII | 525 |
DVIII | 526 |
DIX | 528 |
DXII | 529 |
DXV | 530 |
DXVII | 531 |
DXVIII | 532 |
DXIX | 534 |
DXXI | 536 |
DXXIII | 537 |
DXXIV | 539 |
DXXVIII | 542 |
DXXIX | 543 |
DXXX | 544 |
DXXXI | 545 |
DXXXII | 546 |
DXXXIII | 547 |
DXXXV | 549 |
DXXXVII | 550 |
DXXXVIII | 551 |
DXL | 552 |
DXLI | 553 |
DXLIII | 554 |
DXLVIII | 555 |
DL | 563 |
DLI | 564 |
DLIII | 565 |
DLV | 566 |
DLVI | 567 |
DLVIII | 568 |
DLIX | 569 |
DLX | 571 |
DLXI | 574 |
DLXIII | 576 |
DLXIV | 578 |
DLXV | 579 |
DLXVII | 580 |
DLXIX | 581 |
DLXXI | 582 |
DLXXII | 583 |
DLXXIII | 586 |
DLXXV | 587 |
DLXXVI | 588 |
DLXXVII | 591 |
DLXXVIII | 592 |
DLXXIX | 593 |
DLXXXI | 595 |
DLXXXIII | 596 |
DLXXXIV | 597 |
DLXXXV | 600 |
DLXXXVII | 602 |
DLXXXIX | 603 |
DXC | 605 |
DXCII | 607 |
DXCIII | 608 |
DXCIV | 609 |
DXCV | 610 |
DXCVIII | 612 |
DXCIX | 614 |
DC | 615 |
DCI | 623 |
DCII | 625 |
DCIII | 627 |
DCIV | 628 |
DCV | 629 |
DCVI | 630 |
DCVII | 631 |
DCVIII | 632 |
DCXI | 633 |
DCXIII | 635 |
DCXIV | 636 |
DCXV | 637 |
DCXVI | 639 |
DCXVII | 641 |
DCXVIII | 642 |
DCXX | 643 |
DCXXI | 644 |
DCXXIV | 645 |
DCXXVII | 646 |
DCXXIX | 647 |
DCXXX | 648 |
DCXXXI | 661 |
DCXXXII | 662 |
DCXXXIII | 664 |
DCXXXIV | 666 |
DCXXXV | 668 |
DCXXXVI | 670 |
DCXXXIX | 671 |
DCXLI | 672 |
DCXLIII | 673 |
DCXLIV | 674 |
DCXLV | 677 |
DCXLVI | 679 |
DCXLVIII | 680 |
DCXLIX | 682 |
DCL | 683 |
DCLII | 684 |
DCLIII | 686 |
DCLV | 687 |
DCLVI | 691 |
DCLX | 692 |
DCLXI | 693 |
DCLXII | 694 |
DCLXIV | 695 |
DCLXV | 696 |
DCLXVI | 699 |
DCLXVIII | 700 |
DCLXIX | 701 |
DCLXXI | 707 |
DCLXXII | 708 |
DCLXXIV | 709 |
DCLXXV | 710 |
DCLXXIX | 711 |
DCLXXXI | 712 |
DCLXXXIV | 713 |
DCLXXXV | 714 |
DCLXXXVI | 715 |
DCLXXXVII | 716 |
DCLXXXIX | 718 |
DCXC | 721 |
DCXCI | 722 |
DCXCII | 723 |
DCXCIV | 724 |
DCXCVII | 725 |
DCXCVIII | 726 |
DCXCIX | 728 |
DCCI | 729 |
DCCIII | 730 |
DCCV | 731 |
DCCVI | 732 |
DCCVII | 733 |
DCCVIII | 735 |
DCCXIII | 737 |
DCCXIV | 739 |
DCCXVI | 740 |
DCCXVII | 741 |
DCCXVIII | 742 |
DCCXXI | 743 |
DCCXXIII | 744 |
DCCXXIV | 745 |
DCCXXVI | 746 |
DCCXXVIII | 747 |
DCCXXIX | 748 |
DCCXXX | 749 |
DCCXXXI | 750 |
DCCXXXIII | 751 |
DCCXXXV | 753 |
DCCXXXVII | 755 |
DCCXXXVIII | 756 |
DCCXL | 757 |
DCCXLII | 758 |
DCCXLIII | 759 |
DCCXLIV | 761 |
DCCXLV | 762 |
DCCXLVI | 763 |
DCCXLVIII | 764 |
DCCLI | 765 |
DCCLII | 766 |
DCCLIII | 767 |
DCCLVI | 768 |
DCCLVII | 769 |
DCCLX | 771 |
DCCLXII | 772 |
DCCLXIII | 773 |
DCCLXV | 774 |
DCCLXVI | 775 |
DCCLXVII | 776 |
DCCLXIX | 777 |
DCCLXXI | 779 |
DCCLXXII | 780 |
DCCLXXIV | 781 |
DCCLXXVI | 782 |
DCCLXXIX | 783 |
DCCLXXXII | 784 |
DCCLXXXIII | 785 |
DCCLXXXIV | 786 |
DCCLXXXV | 787 |
DCCLXXXVI | 788 |
DCCLXXXIX | 789 |
DCCXC | 790 |
DCCXCI | 791 |
DCCXCIII | 792 |
DCCXCV | 793 |
DCCXCVIII | 794 |
DCCXCIX | 795 |
DCCCI | 796 |
DCCCV | 797 |
DCCCVI | 798 |
DCCCVIII | 813 |
DCCCIX | 815 |
DCCCX | 816 |
DCCCXII | 817 |
DCCCXIII | 818 |
DCCCXIV | 819 |
DCCCXVII | 821 |
DCCCXVIII | 822 |
DCCCXIX | 824 |
DCCCXX | 825 |
DCCCXXI | 826 |
DCCCXXII | 828 |
DCCCXXIII | 829 |
DCCCXXIV | 830 |
DCCCXXV | 831 |
DCCCXXVI | 833 |
DCCCXXVII | 834 |
DCCCXXVIII | 835 |
DCCCXXIX | 836 |
DCCCXXXI | 837 |
DCCCXXXII | 838 |
DCCCXXXIII | 840 |
DCCCXXXIV | 841 |
DCCCXXXV | 843 |
DCCCXXXVII | 857 |
DCCCXXXVIII | 858 |
DCCCXXXIX | 859 |
DCCCXLII | 863 |
DCCCXLIV | 864 |
DCCCXLV | 865 |
DCCCXLVI | 866 |
DCCCXLVII | 867 |
DCCCXLVIII | 868 |
DCCCL | 869 |
DCCCLI | 870 |
DCCCLIII | 871 |
DCCCLV | 872 |
DCCCLVI | 873 |
DCCCLVIII | 874 |
DCCCLX | 875 |
DCCCLXI | 880 |
DCCCLXIV | 881 |
DCCCLXVII | 882 |
DCCCLXX | 883 |
DCCCLXXI | 884 |
DCCCLXXIII | 885 |
DCCCLXXIV | 886 |
DCCCLXXVI | 887 |
DCCCLXXVII | 888 |
DCCCLXXVIII | 893 |
DCCCLXXIX | 894 |
DCCCLXXX | 896 |
DCCCLXXXI | 900 |
DCCCLXXXIII | 912 |
DCCCLXXXIV | 918 |
DCCCLXXXVI | 923 |
DCCCLXXXVII | 933 |
935 | |
Citi izdevumi - Skatīt visu
Biotechnology and the Law Hugh B. Wellons,Robert F. Copple,Bill Wofford Priekšskatījums nav pieejams - 2020 |
Bieži izmantoti vārdi un frāzes
addition agency agreement amended animal drugs approval authorization Bayh-Dole Act biological product biotech company biotechnology biotechnology company cell chapter claims clinical trials collaboration commercial company's compliance conduct confidentiality contract contractor Covered Entity disclose disclosure documents employee ensure European European Commission European Medicines Agency exemption FDA's federal filing founders funding genetic GMOs grant Guidance hazardous waste HIPAA human IACUC individual infringement Initial Public Offering intellectual property invention investigational investors issues license licensor limited litigation manufacturing medical devices Medicare medicinal products ment option organization parties partner patent application payment pharmaceutical pharmacovigilance potential Practice Points preclinical research prior art Privacy procedures protection registration regulations regulatory requirements risk royalty safety shares specific sponsor tion trade secret trademark VSTA